Research on Werner Syndrome: Trends from Past to Present and Future Prospects

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Oct 27

PMID 36292687

Authors

Kyoshiro Tsuge

Akira Shimamoto

Affiliations

Soon will be listed here.

Abstract

A rare and autosomal recessive premature aging disorder, Werner syndrome (WS) is characterized by the early onset of aging-associated diseases, including shortening stature, alopecia, bilateral cataracts, skin ulcers, diabetes, osteoporosis, arteriosclerosis, and chromosomal instability, as well as cancer predisposition. , the gene responsible for WS, encodes DNA helicase with a 3' to 5' exonuclease activity, and numerous studies have revealed that WRN helicase is involved in the maintenance of chromosome stability through actions in DNA, e.g., DNA replication, repair, recombination, and epigenetic regulation via interaction with DNA repair factors, telomere-binding proteins, histone modification enzymes, and other DNA metabolic factors. However, although these efforts have elucidated the cellular functions of the helicase in cell lines, they have not been linked to the treatment of the disease. Life expectancy has improved for WS patients over the past three decades, and it is hoped that a fundamental treatment for the disease will be developed. Disease-specific induced pluripotent stem (iPS) cells have been established, and these are expected to be used in drug discovery and regenerative medicine for WS patients. In this article, we review trends in research to date and present some perspectives on WS research with regard to the application of pluripotent stem cells. Furthermore, the elucidation of disease mechanisms and drug discovery utilizing the vast amount of scientific data accumulated to date will be discussed.

Citing Articles

Specific Monitoring the DNA Helicase Function via Anchor-Embedded DNA Probe.

Ning K, Tang X, Li Z, Zhong L, Zhou Y, Wang J Adv Sci (Weinh). 2024; 12(8):e2413368.

PMID: 39737862 PMC: 11848566. DOI: 10.1002/advs.202413368.

Werner syndrome RECQ helicase participates in and directs maintenance of the protein complexes of constitutive heterochromatin in proliferating human cells.

Lazarchuk P, Nguyen M, Curca C, Pavlova M, Oshima J, Sidorova J Aging (Albany NY). 2024; 16(20):12977-13011.

PMID: 39422615 PMC: 11552638. DOI: 10.18632/aging.206132.

Genetic insights into the complexity of premature ovarian insufficiency.

Nie L, Wang X, Wang S, Hong Z, Wang M Reprod Biol Endocrinol. 2024; 22(1):94.

PMID: 39095891 PMC: 11295921. DOI: 10.1186/s12958-024-01254-2.

Sclerosing epithelioid fibrosarcoma associated with WRN gene variant presenting as chronic dyspnea and pathologic cervical fracture: a case report and review of the literature.

Phan A, Ghantarchyan H, Khosravi C, Maknouni B, Bhagat A, Chen J J Med Case Rep. 2023; 17(1):517.

PMID: 38104125 PMC: 10725598. DOI: 10.1186/s13256-023-04249-6.

Telomere length as a predictive biomarker in osteoporosis (Review).

Kakridonis F, Pneumatikos S, Vakonaki E, Berdiaki A, Tzatzarakis M, Fragkiadaki P Biomed Rep. 2023; 19(5):87.

PMID: 37881605 PMC: 10594068. DOI: 10.3892/br.2023.1669.

References

Kitao S, Ohsugi I, Ichikawa K, Goto M, Furuichi Y, Shimamoto A . Cloning of two new human helicase genes of the RecQ family: biological significance of multiple species in higher eukaryotes. Genomics. 1999; 54(3):443-52. DOI: 10.1006/geno.1998.5595. View

Dimri G, Martinez J, Jacobs J, Keblusek P, Itahana K, van Lohuizen M . The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 2002; 62(16):4736-45. View

Chan E, Shibue T, McFarland J, Gaeta B, Ghandi M, Dumont N . WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019; 568(7753):551-556. PMC: 6580861. DOI: 10.1038/s41586-019-1102-x. View

Bulut-Karslioglu A, de la Rosa-Velazquez I, Ramirez F, Barenboim M, Onishi-Seebacher M, Arand J . Suv39h-dependent H3K9me3 marks intact retrotransposons and silences LINE elements in mouse embryonic stem cells. Mol Cell. 2014; 55(2):277-90. DOI: 10.1016/j.molcel.2014.05.029. View

Karmakar P, Bohr V . Cellular dynamics and modulation of WRN protein is DNA damage specific. Mech Ageing Dev. 2005; 126(11):1146-58. DOI: 10.1016/j.mad.2005.06.004. View

Wolf D, Goff S . Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature. 2009; 458(7242):1201-4. PMC: 2676211. DOI: 10.1038/nature07844. View

Crabbe L, Jauch A, Naeger C, Holtgreve-Grez H, Karlseder J . Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci U S A. 2007; 104(7):2205-10. PMC: 1794219. DOI: 10.1073/pnas.0609410104. View

von Kobbe C, Bohr V . A nucleolar targeting sequence in the Werner syndrome protein resides within residues 949-1092. J Cell Sci. 2002; 115(Pt 20):3901-7. DOI: 10.1242/jcs.00076. View

Edwards D, Machwe A, Wang Z, Orren D . Intramolecular telomeric G-quadruplexes dramatically inhibit DNA synthesis by replicative and translesion polymerases, revealing their potential to lead to genetic change. PLoS One. 2014; 9(1):e80664. PMC: 3891601. DOI: 10.1371/journal.pone.0080664. View

10.

De Cecco M, Criscione S, Peckham E, Hillenmeyer S, Hamm E, Manivannan J . Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell. 2013; 12(2):247-56. PMC: 3618682. DOI: 10.1111/acel.12047. View

11.

Lago S, Nadai M, Cernilogar F, Kazerani M, Dominiguez Moreno H, Schotta G . Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome. Nat Commun. 2021; 12(1):3885. PMC: 8222265. DOI: 10.1038/s41467-021-24198-2. View

12.

Vazquez B, Thackray J, Simonet N, Chahar S, Kane-Goldsmith N, Newkirk S . SIRT7 mediates L1 elements transcriptional repression and their association with the nuclear lamina. Nucleic Acids Res. 2019; 47(15):7870-7885. PMC: 6735864. DOI: 10.1093/nar/gkz519. View

13.

Sakamoto S, Nishikawa K, Heo S, Goto M, Furuichi Y, Shimamoto A . Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells. 2001; 6(5):421-30. DOI: 10.1046/j.1365-2443.2001.00433.x. View

14.

Takemoto M, Mori S, Kuzuya M, Yoshimoto S, Shimamoto A, Igarashi M . Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey. Geriatr Gerontol Int. 2012; 13(2):475-81. DOI: 10.1111/j.1447-0594.2012.00913.x. View

15.

Edwards D, Machwe A, Chen L, Bohr V, Orren D . The DNA structure and sequence preferences of WRN underlie its function in telomeric recombination events. Nat Commun. 2015; 6:8331. PMC: 4589872. DOI: 10.1038/ncomms9331. View

16.

Mori H, Tomiyama T, Maeda N, Ozawa K, Wakasa K . Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome. Neuropathology. 2003; 23(1):51-6. DOI: 10.1046/j.1440-1789.2003.00474.x. View

17.

Abu-Libdeh B, Jhujh S, Dhar S, Sommers J, Datta A, Longo G . RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1. J Clin Invest. 2022; 132(5). PMC: 8884905. DOI: 10.1172/JCI147301. View

18.

Zhu X, Zhang G, Kang L, Guan H . Epigenetic Regulation of Werner Syndrome Gene in Age-Related Cataract. J Ophthalmol. 2015; 2015:579695. PMC: 4609838. DOI: 10.1155/2015/579695. View

19.

Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M . Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture. PLoS One. 2014; 9(11):e112900. PMC: 4229309. DOI: 10.1371/journal.pone.0112900. View

20.

Paes Dias M, Moser S, Ganesan S, Jonkers J . Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nat Rev Clin Oncol. 2021; 18(12):773-791. DOI: 10.1038/s41571-021-00532-x. View